Lechi Ye

1.9k citations
48 papers · 1.4k indexed · 1 hit paper · h-index 18

Impact in

  • Hepatology top 2%
    • Hepatocellular Carcinoma Treatment and Prognosis
    • Cancer-related molecular mechanisms research

Papers in

Lechi Ye

46 papers receiving 1.4k citations

Hit Papers

Cetuximab promotes RSL3-induced ferroptosis by suppressing the Nrf2/HO-1 signalling pathway in KRAS mutant colorectal cancer 2021 · 225 citations
225202120262022202450100150200

Peers

Lechi Ye
Comparison fields: 5 of 89
  • Hepatology 354
  • Cancer Research 511
  • Oncology 628
  • Pulmonary and Respiratory Medicine 396
  • Molecular Biology 589
Replace Cheol-Keun Park with:
Cheol-Keun Park South Korea
Xinsen Xu China
Luca Faloppi Italy
Giorgia Marisi Italy
Ao Huang China
Stratigoula Sakellariou Greece
Manuel Valladares‐Ayerbes Spain
Enxiao Li China
Jeong Eun Yoo South Korea
Genshu Wang China
Lechi Ye relative to Cheol-Keun Park South Korea Cheol-Keun Park's profile →
Citations per field
00.5×3.7×
Cheol-Keun Park · 1×
Citations per year

Countries citing papers authored by Lechi Ye

Since Specialization
Citations

This map shows the geographic impact of Lechi Ye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lechi Ye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lechi Ye more than expected).

Fields of papers citing papers by Lechi Ye

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lechi Ye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lechi Ye. The network helps show where Lechi Ye may publish in the future.

Co-authors

The 25 scholars most cited alongside Lechi Ye, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Lechi Ye Line = papers co-authored together Lechi Ye links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2013296
2
Cetuximab promotes RSL3-induced ferroptosis by suppressing the Nrf2/HO-1 signalling pathway in KRAS mutant colorectal cancer
Hit paper breakdown →
2021225
3 2014193
4 201270
5 201660
6 201443
7 201637
8 201436
9 201535
10 201534
11 201532
12 201432
13 202323
14 201722
15 201722
16 201422
17 201521
18 201519
19 201917
20 201516

About Lechi Ye

Lechi Ye is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Surgery and Cancer Research, having authored 48 papers that have together received 1.4k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (15 papers), Hepatocellular Carcinoma Treatment and Prognosis (10 papers), Gastric Cancer Management and Outcomes (6 papers), Cancer-related molecular mechanisms research (6 papers), Colorectal Cancer Surgical Treatments (5 papers), RNA modifications and cancer (5 papers), Ferroptosis and cancer prognosis (5 papers) and Autophagy in Disease and Therapy (4 papers). The work is most often cited by research in Hepatology (354 citations), Cancer Research (511 citations), Oncology (628 citations), Pulmonary and Respiratory Medicine (396 citations) and Molecular Biology (589 citations). Lechi Ye has collaborated with scholars based in China, United States and Spain. Frequent co-authors include Ye Wei, Jianmin Xu, Dexiang Zhu, Li Ren, Xinyu Qin, Qing‐Hai Ye, Juji Dai, Tianshu Liu, Wei Cen and Junjun Qiu. Their work appears in journals such as PLoS ONE, Tumor Biology, Annals of Surgical Oncology, Journal of Clinical Oncology and Cell Death and Disease.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact